|
1
|
Manns MP, Buti M, Gane E, Pawlotsky JM,
Razavi H, Terrault N and Younossi Z: Hepatitis C virus infection.
Nat Rev Dis Primers. 3:170062017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Park SH and Rehermann B: Immune responses
to HCV and other hepatitis viruses. Immunity. 40:13–24. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferrari SM, Fallahi P, Mancusi C, Colaci
M, Manfredi A, Ferri C and Antonelli A: HCV-related autoimmune
disorders in HCV chronic infection. Clin Ter. 164:e305–e312.
2013.PubMed/NCBI
|
|
4
|
Moir S and Fauci AS: B cells in HIV
infection and disease. Nat Rev Immunol. 9:235–245. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sang A, Zheng YY and Morel L:
Contributions of B cells to lupus pathogenesis. Mol Immunol.
62:329–338. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Perry HM, Bender TP and McNamara CA: B
cell subsets in atherosclerosis. Front Immunol. 3:3732012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sugalski JM, Rodriguez B, Moir S and
Anthony DD: Peripheral blood B cell subset skewing is associated
with altered cell cycling and intrinsic resistance to apoptosis and
reflects a state of immune activation in chronic hepatitis C virus
infection. J Immunol. 185:3019–3027. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Holz LE, Yoon JC, Raghuraman S, Moir S,
Sneller MC and Rehermann B: B cell homeostasis in chronic hepatitis
C virus-related mixed cryoglobulinemia is maintained through naïve
B cell apoptosis. Hepatology. 56:1602–1610. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Racanelli V, Frassanito MA, Leone P,
Galiano M, De Re V, Silvestris F and Dammacco F: Antibody
production and in vitro behavior of CD27-defined B-cell subsets:
Persistent hepatitis C virus infection changes the rules. J Virol.
80:3923–3934. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Mizuochi T, Ito M, Saito K, Kasai M,
Kunimura T, Morohoshi T, Momose H, Hamaguchi I, Takai K, Iino S, et
al: Possible recruitment of peripheral blood CXCR3+ CD27+ CD19+ B
cells to the liver of chronic hepatitis C patients. J Interferon
Cytokine Res. 30:243–252. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rosa D, Saletti G, De Gregorio E, Zorat F,
Comar C, D'Oro U, Nuti S, Houghton M, Barnaba V, Pozzato G and
Abrignani S: Activation of naïve B lymphocytes via CD81, a
pathogenetic mechanism for hepatitis C virus-associated B
lymphocyte disorders. Proc Natl Acad Sci USA. 102:pp. 18544–18549.
2005; View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Oliviero B, Cerino A, Varchetta S, Paudice
E, Pai S, Ludovisi S, Zaramella M, Michelone G, Pugnale P, Negro F,
et al: Enhanced B-cell differentiation and reduced proliferative
capacity in chronic hepatitis C and chronic hepatitis B virus
infections. J Hepatol. 55:53–60. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oliviero B, Mantovani S, Ludovisi S,
Varchetta S, Mele D, Paolucci S, Baldanti F and Mondelli MU: Skewed
B cells in chronic hepatitis C virus infection maintain their
ability to respond to virus-induced activation. J Viral Hepat.
22:391–398. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Valle L Della, Dohmen SE, Verhagen OJ,
Berkowska MA, Vidarsson G and van der Schoot C Ellen: The majority
of human memory B cells recognizing RhD and tetanus resides in IgM+
B cells. J Immunol. 193:1071–1079. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
D'Orsogna LJ, Krueger RG, McKinnon EJ and
French MA: Circulating memory B-cell subpopulations are affected
differently by HIV infection and antiretroviral therapy. AIDS.
21:1747–1752. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Carsetti R, Rosado MM, Donnanno S, Guazzi
V, Soresina A, Meini A, Plebani A, Aiuti F and Quinti I: The loss
of IgM memory B cells correlates with clinical disease in common
variable immunodeficiency. J Allergy Clin Immunol. 115:412–417.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Roughan JE, Reardon KM, Cogburn KE,
Quendler H, Pockros PJ and Law M: Chronic hepatitis C virus
infection breaks tolerance and drives polyclonal expansion of
autoreactive B cells. Clin Vaccine Immunol. 19:1027–1037. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rao H, Wei L, Lopez-Talavera JC, Shang J,
Chen H, Li J, Xie Q, Gao Z, Wang L, Wei J, et al: Distribution and
clinical correlates of viral and host genotypes in Chinese patients
with chronic hepatitis C virus infection. J Gastroenterol Hepatol.
29:545–553. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo Z, Zhang H, Rao H, Jiang D, Cong X,
Feng B, Wang J, Wei L and Chen H: DCs pulsed with novel
HLA-A2-restricted CTL epitopes against hepatitis C virus induced a
broadly reactive anti-HCV-specific T lymphocyte response. PLoS One.
7:e383902012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Hardy RR: B-1 B cell development. J
Immunol. 177:2749–2754. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Curry MP, Golden-Mason L, Nolan N, Parfrey
NA, Hegarty JE and O'Farrelly C: Expansion of peripheral blood CD5+
B cells is associated with mild disease in chronic hepatitis C
virus infection. J Hepatol. 32:121–125. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Perez-Andres M, Paiva B, Nieto WG, Caraux
A, Schmitz A, Almeida J, Vogt RF Jr, Marti GE, Rawstron AC, Van
Zelm MC, et al: Human peripheral blood B-cell compartments: A
crossroad in B-cell traffic. Cytometry B Clin Cytom. 78 Suppl
1:S47–S60. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bemark M, Holmqvist J, Abrahamsson J and
Mellgren K: Translational Mini-Review Series on B cell subsets in
disease. Reconstitution after haematopoietic stem cell
transplantation-revelation of B cell developmental pathways and
lineage phenotypes. Clin Exp Immunol. 167:15–25. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma L, Qin J, Ji H, Zhao P and Jiang Y: Tfh
and plasma cells are correlated with hypergammaglobulinaemia in
patients with autoimmune hepatitis. Liver Int. 34:405–415. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang J, Shan Y, Jiang Z, Feng J, Li C, Ma
L and Jiang Y: High frequencies of activated B cells and T
follicular helper cells are correlated with disease activity in
patients with new-onset rheumatoid arthrits. Clin Exp Immunol.
174:212–220. 2013.PubMed/NCBI
|
|
26
|
Youinou P and Renaudineau Y: CD5
expression in B cells from patients with systemic lupus
erythematosus. Crit Rev Immunol. 31:31–42. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dörner T, Giesecke C and Lipsky PE:
Mechanisms of B cell autoimmunity in SLE. Arthritis Res Ther.
13:2432011. View
Article : Google Scholar : PubMed/NCBI
|
|
28
|
Deterre P, Berthelier V, Bauvois B,
Dalloul A, Schuber F and Lund F: CD38 in T- and B-cell functions.
Chem Immunol. 75:146–168. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kong FY, Feng B, Zhang HH, Rao HY, Wang
JH, Cong X and Wei L: CD4+CXCR5+ T cells activate CD27+IgG+ B cells
via IL-21 in patients with hepatitis C virus infection.
Hepatobiliary Pancreat Dis Int. 15:55–64. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lim TS, Goh JK, Mortellaro A, Lim CT,
Hämmerling GJ and Ricciardi-Castagnoli P: CD80 and CD86
differentially regulate mechanical interactions of T-cells with
antigen-presenting dendritic cells and B-cells. PLoS One.
7:e451852012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Strasser A, Jost PJ and Nagata S: The many
roles of FAS receptor signaling in the immune system. Immunity.
30:180–192. 2009. View Article : Google Scholar : PubMed/NCBI
|
